Assessing Urinary Para-Hydroxyphenylacetic Acid as a Biomarker Candidate in Neuroendocrine Neoplasms
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212317 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Renato de Falco und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Unit, Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Biomarkers, Tumor, Phenylacetates. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Italian Ministry of Health Ricerca 5×1000 Funds, year 2023, “Potenziamento della sinergia tra l’attività di ricerca e quella di assistenza”.
Abstract (Originalsprache)
The management of neuroendocrine neoplasms (NENs) involves the measurement of serum chromogranin A (s-CGA), serum neuro-specific enolase (s-NSE), and urinary 5-hydroxindolacetic acid (5-HIAA). Urinary para-hydroxyphenylacetic acid (u-pHPAA), a metabolite of tyrosine, has been proposed as a potential biomarker for these diseases. This study aims to evaluate the effectiveness of u-pHPAA and tyrosine as biomarkers. We measured the levels of s-CgA, s-NSE, u-5-HIAA, u-pHPAA, and tyrosine in blood or 24 h urine samples collected at baseline (T0) and after 1 year of follow-up (T1) from a limited cohort of patients enrolled at Istituto Nazionale Tumori-IRCCS-Fondazione “G. Pascale”. Biomarker values were normalized using the ratios between T1 and T0 values (T1/T0 parameters). The T1/T0 ratios for s-CgA and u-pHPAA were significantly associated with the outcome of death (p = 0.044 and p = 0.022, respectively). An ROC curve analysis demonstrated outstanding performances for these biomarkers (AUC = 0.958 and AUC = 1.00, respectively) and the Kaplan–Meier survival analysis showed significant Log-rank test results (p = 0.001 and p < 0.001, respectively). Additionally, T0 serum tyrosine correlated with the outcome of death (p = 0.044), with the ROC curve showing good performance (AUC = 0.958) and the Kaplan–Meier analysis yielding significant Log-rank test results (p = 0.007). Our study confirms the role of s-CgA in the management of NEN patients and highlights the potential roles of u-pHPAA and serum tyrosine as biomarkers. Further research is needed to validate our findings in larger populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Medicine Unit, Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy.
- Experimental Pharmacology Unit, Laboratories of Naples and Mercogliano (AV), Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy.
- Sarcoma and Rare Tumors Unit, Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale", 80131 Naples, Italy.
ORCID-Profile: Renato de Falco, Susan Costantini, Luigi Russo, Anita Minopoli, Ottavia Clemente, Salvatore Tafuto, Elena Di Gennaro, Alfredo Budillon, Ernesta Cavalcanti
Förderung
- Italian Ministry of Health
- Italian Ministry of Health Ricerca 5×1000 Funds, year 2023, “Potenziamento della sinergia tra l’attività di ricerca e quella di assistenza”
Zitieren
APA
de Falco, R., Costantini, S., Russo, L., Giannascoli, D., Minopoli, A., Clemente, O., Tafuto, S., Vitagliano, C., Di Gennaro, E., Budillon, A., & Cavalcanti, E. (2024). Assessing Urinary Para-Hydroxyphenylacetic Acid as a Biomarker Candidate in Neuroendocrine Neoplasms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212317
Vancouver
de Falco R, Costantini S, Russo L, Giannascoli D, Minopoli A, Clemente O, et al. Assessing Urinary Para-Hydroxyphenylacetic Acid as a Biomarker Candidate in Neuroendocrine Neoplasms. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212317
BibTeX
@article{deFalco2024,
author = {de Falco, Renato and Costantini, Susan and Russo, Luigi and Giannascoli, Denise and Minopoli, Anita and Clemente, Ottavia and Tafuto, Salvatore and Vitagliano, Carlo and Di Gennaro, Elena and Budillon, Alfredo and Cavalcanti, Ernesta},
title = {Assessing Urinary Para-Hydroxyphenylacetic Acid as a Biomarker Candidate in Neuroendocrine Neoplasms},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212317}
}
EUVIMED